^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    polyinosinic:polycytidylic acid (BO-112)

    i
    Associations
    News
    Trials
    Company:
    Highlight Therap
    Drug class:
    TLR3 agonist, EIF2AK2 activator, IFIH1 activator, PMAIP1 stimulant, RIG-I stimulant
    Related drugs:
    Associations
    News
    Trials